Molecule Details
| InChIKey | VOKSWYLNZZRQPF-UHFFFAOYSA-N |
|---|---|
| Compound Name | Talwin |
| Canonical SMILES | CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.04 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00652 |
|---|---|
| Drug Name | Pentazocine |
| CAS Number | 359-83-1 |
| Groups | approved vet_approved |
| ATC Codes | N02AD51 N02AD01 |
| Description | The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) |
Categories: Adjuvants, Anesthesia Agents that reduce seizure threshold Alkaloids Analgesics Benzomorphan Derivatives Benzomorphans Central Nervous System Agents Central Nervous System Depressants Heterocyclic Compounds, Fused-Ring Mixed Agonist / Antagonist Opioids Morphinans Narcotics Nervous System Opiate Alkaloids Opiate Partial Agonists Opioid Antagonists Opioids P-glycoprotein substrates Partial Opioid Agonist/Antagonist Peripheral Nervous System Agents Phenanthrenes Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Cross-references: BindingDB: 50032403 ChEBI: 182080 CHEMBL100116 ChemSpider: 4574 Drugs Product Database (DPD): 9401 Guide to Pharmacology: 1606 IUPHAR: 1606 C07421 D00498 PharmGKB: PA164744326 PubChem:441278 PubChem:46506363 RxCUI: 8001 Therapeutic Targets Database: DAP000356 Wikipedia: Pentazocine ZINC: ZINC000000000596